Bone density, bone markers and bone radiological features in mastocytosis

Age and Ageing

Volumn 25, Issue 1, 1996, Pages 1-7

  Johansson, Christer ^a   Roupe, Gösta ^b   Lindstedt, Göran ^b   Mellström, Dan ^a  

^a Vasa Hospital   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HEPARIN; HISTAMINE; PROSTAGLANDIN D2;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE RADIOGRAPHY; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HIP; HISTAMINE METABOLISM; HUMAN; MALE; MAST CELL; MASTOCYTOSIS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OSTEOSCLEROSIS; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; VERTEBRA FRACTURE;

ACID PHOSPHATASE; ADULT; AGED; ALKALINE PHOSPHATASE; BONE DENSITY; FEMALE; HIP; HUMANS; ILIUM; IMIDAZOLES; INSULIN-LIKE GROWTH FACTOR I; ISOENZYMES; MALE; MIDDLE AGED; OSTEOCALCIN; SPINE; URTICARIA PIGMENTOSA;

EID: 0030047040     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/25.1.1     Document Type: Article

References (27)

1. Rafii M, Firooznia H, Golimbu C, Balthazar E. Pathologic fracture in systemic mastocytosis: radiographic spectrum and review of the literature. Clin Orthop Rel Res 1983;180:260-7.
2. Roupe G. Urticaria pigmentosa and systemic mastocytosis. Semin Dermatol 1987;6:334-41.
3. Ridell B, Olafsson JH, Roupe G, et al. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Arch Dermatol 1986;122:422-7.
4. Fogelman I, Ryan P. Measurement of bone mass. Bone 1992;13:S23-8.
5. Christiansen C, Rodbro P, Jensen H. Bone mineral content in the forearm measured by photon absorptiometry. Scand J Clin Lab Invest 1975;35:323-7.
6. Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended method for the determination of four enzymes in blood. Scand J Clin Lab Invest 1974;33:291-306.
7. Melton LJ III, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989;129:1000-11.
8. Thomas AE, McKay DA, Cutlip MB. A nomograph method for assessing body weight. Am J Clin Nutr 1976; 29:302-4.
9. Enerbäck L. Mast cells, In: Spicer SS, ed: Histochemistry Pathologic Diagnosis. New York: Marcel Dekker, 1986; 695-727.
10. De Vernejoul MC, Kuntz D, Miravet-Goutaillier D, Ryckewaert A. Bone histomorphometry reproducibility in normal patients. Calcif Tissue Res 1981;33:369-74.
11. Odén A, Wedel H. Arguments for Fisher's permutation test. Am Stat 1975;3:518-20.
12. Stracke H, Shulz A, Moeller D, Rossol S, Schatz H. Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture. Acta Endocrinol 1984;107:16-24.
13. Stein DH. Mastocytosis: a review. Ped Dermatol 1986;3: 365-75.
14. Schratter M, Canigiani G, Schönbaur Ch, Mach K. Radiologischer Beitrag zu den Skelettveränderungen der 'systemischen Mastocytose' - Urticaria pigmentosa. Rontgenblatter 1983;336:359-62.
15. Frame B, Nixon RK. Bone-marrow mast cells in osteoporosis of aging. N Engl J Med 1968;279:626-30.
16. Griffith GC, Nichols Jr G, Asher, JD, Flanagan B. Heparin osteoporosis. JAMA 1965;193:85-8.
17. Fallon MD, Whyte MP, Teitelbaum SL. Systemic mastocytosis associated with generalized osteopenia: Histopathological characterization of skeletal lesion using undecalcified bone from two patients. Hum Pathol 1981;12:813-20.
18. Goldhaber P. Heparin enhancement of factors stimulating bone resorption in tissue culture. Science 1965;147: 407-9.
19. Chines A, Pacifici R, Avioli LV, Teitelbaum SL, Korenblat PE. Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study. J Clin Endocrinol Metab 1991;72:140-4.
20. Sakamoto S, Sakamoto M. Effects of heparin on bone collagens release and activity and an application of heparin-sepharose affinity chromatography for in vitro study of bone resorption. Heparin and bone metabolism Amsterdam: Elsevier North Holland Inc., 1981;133-42.
21. Travis WD, Li C-Y, Bergstralh EJ, Yama LT, Swee RG. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 1988;67:345-68.
22. McKenna MJ, Frame B. The mast cell and bone. Clin Orthop Rel Res 1985;200:226-33.
23. Melsen F, Mosekilde L. Tetracycline double labeling of iliac trabeculum bone in 41 normal adults. Calcif Tissue Res 1978;26:99-102.
24. Åkesson K, Ljunghall S, Gärdsell P, Sernbo I, Obrant KJ. Serum osteocalcin and fracture susceptibility in elderly women. Calcif Tissue Int 1993;53:86-90.
25. Epstein SRM, Bryce G, Poser J, Johnston CCJ, Hui S. Differences in serum bone Gla-protein with age and sex. Lancet 1984;i:307-10.
26. Coleman RE, Mashiter G, Fogelman I, et al. Osteocalcin: a potential marker of metastatic bone disease and response of treatment. Eur J Cancer Clin Oncol 1988;24:1211-17.
27. Cundy T, Beneton MNC, Darby AJ, Marshall WJ, Kanis JA. Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption. Bone 1987;8:149-55.